Congrats to Dr Colin Johnson on his presentation on 6 year follow up of fertility patients’ regret surrounding fertility treatments! mcwobgyn @ReprodMed #ASRM2020 Jay Sandlow, MD Rachel Cusatis

👻

Just replace ‘one sentence’ with ‘one bullet point in a preso’...#same. 🙋🏻‍♀️

Just got student evals back from last semester and I definitely shed some happy tears from their kind words... "Online is hard, but Dr. Cusatis made it work" 🥲

Check out the new DETA Update | March 2021 - mailchi.mp/053783b2fa7d/d… | Topics included equity and bias, COVID-19 research resources, and upcoming events and conferences.

Qualitative methods, mixed methods, quantitative methods.

If you are attending #ASH21 don't forget to check out #BMTCTN abstract presentations!

Attending #ASH21? CIBMTR investigators will present >30 abstracts, this weekend. Take a look at today’s abstract presentations below and see the full list on our website! ms.spr.ly/6012ZBOum

#ASH21 #cartsm Coming up shortly: Our work on financial toxicity in pts undergoing CAR-T therapy. Joint study at Stanford BMT & Cell Therapy and MCW. Will be presented by Dr Cusatis.

Worsening Financial Toxicity Among Pts Receiving CAR-T: Longitudinal Study ➡️ COST-FACIT scores highest @ baseline: indicates higher financial well-being; large range suggests pts come into CAR-T at different levels of financial tox. ➡️ Financial well-being declined over time

Not surprisingly, patients experience financial toxicity following #CARTcell #CellTherapy as presented by Rachel Cusatis at #ASH21. Their qualitative data highlight the need for additional support for lodging and relocation in order to ensure #accesstocare Lori Muffly @adsouza_md

#ASH21 Financial toxicity with CAR-T therapy, excellent presentation by Rachel Cusatis! Lori Muffly Stanford BMT & Cell Therapy - Increasing FT with time -Lodging, travel, insurance coverage, need to give up other things are common themes

🙏 Surbhi Sidana, MD @adsouza_md et al for addressing important #ASH21 topic: financial toxicity with #TcellRx. SW colleagues are EXCELLENT at supporting pts leading into CAR-T therapy, but more work needed on other side. CAR-T outcomes: Achieving MRD-neg 👍, creating GoFundMe 👎

One of our current top ten articles: Adding centralized electronic patient-reported outcome (PRO) data collection to an established international clinical outcomes registry. Rachel Cusatis et al in Transplantation and Cellular Therapy Journal stemcellevidence.com/article/347572… #BMT #StemCellEvidence

Looking forward to hearing various perspectives from #BMTCTN 1102 study Co-Chair Corey Cutler, #BMTCTN Evidence into Practice members Drs. Chandra & Kindwall-Keller & #BMTCTN QOL Cmte member Rachel Cusatis Thanks @BeTheMatch for offering this session to highlight the study findings! x.com/BeTheMatch/sta…

3rd Health Services Oral: CAR-T Recipients & Worsening Financial Impact over Time: A Mixed Methods Longitudinal Study by Rachel Cusatis & coauthors CIBMTR Medical College of Wisconsin Stanford BMT & Cell Therapy tandem.confex.com/tandem/2022/me…

DETAResearch.org Rachel Cusatis @LindseyHarness Read the article and download the infographic on DETAResearch.org's new site, detaresearch.org/news-events/pu….

One of our top ten articles this month: Rachel Cusatis in AmericanJournalofHematology on Health-related quality of life in reduced intensity HSCT based on donor availability in patients aged 50-75 with advanced #MDS stemcellevidence.com/article/362514… #BMT #StemCellEvidence

TOPcast ep130 includes shoutouts to Tanya Joosten DETAResearch.org UW-Milwaukee Rachel Cusatis Katrina Wehr Gould @YESPLZdotCOFFEE and more! bit.ly/topcast_s08e130

The upcoming #virtual Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies program on Sept. 11, features authorities in cancer immunotherapy. Address toxicities beyond CRS and ICANS. Register now: ow.ly/xgfo50T8EpL Matthew Frigault Rachel Cusatis Lori Muffly